Fingenious provides researchers in the academia and life sciences industry a more streamlined access to Finnish registries and biobank samples and data, thus making the Finnish environment more practical for international biomedical research project and product development teams. The digital portal and service are managed by the Finnish Biobank Cooperative (FINBB).

“We are delighted to join the Fingenious® ecosystem! Pharmaca brings additional expertise and data to the ecosystem thanks to our unique background. Our four business areas make us a versatile and strong partner. The data-driven services accelerate product launches, optimize market access, and strengthen commercial strategies. Our goal is to empower organizations to make smart, evidence-based decisions,” says Päivi Rastas, Business Director, Pharmaca Health Intelligence.

Pharmaca’s approach on health data focuses on combining data from multiple sources and making it accessible through one seamless platform. In addition to providing ready-made dashboards, we deliver tailored Real-World Data projects based on Finnish registry data. The capabilities include end-to-end support from study design through data analysis, visualization, and medical writing, as well as project management and guidance on selecting appropriate data sources.

While Fingenious streamlines the access to Finnish health data, Pharmaca complements this with data-driven services that utilize Finnish registry and pharmaceuticals sales data, building insights that support evidence-based, smart decision-making.

• Read more about the partnership of Fingenious and Pharmaca